Showing results (391-400 of 409) with videos related to

Sort By:
Pageof 41
British Journal of Haematology|July 18, 2020
Clinical outcomes and risk factors for severe COVID-19 in patients with haematological disorders receiving chemo- or immunotherapyThomas A Fox, Ethan Troy-Barnes, Amy A Kirkwood, et al.
Blood|February 2, 2021
Redefining outcomes in immune TTP: an international working group consensus reportAdam Cuker, Spero R Cataland, Paul Coppo, et al.
Intensive Care Medicine|July 3, 2025
Thrombotic thrombocytopenic purpura: early diagnosis and effective treatment in 2025Elie Azoulay, Agnès Veyradier, Spero Cataland, et al.
Blood|December 25, 2007
Gas6 promotes inflammation by enhancing interactions between endothelial cells, platelets, and leukocytesMarc Tjwa, Lola Bellido-Martin, Yuan Lin, et al.
Blood Advances|November 27, 2019
Updated international consensus report on the investigation and management of primary immune thrombocytopeniaDrew Provan, Donald M Arnold, James B Bussel, et al.
The New England Journal of Medicine|May 1, 2024
Recombinant ADAMTS13 in Congenital Thrombotic Thrombocytopenic PurpuraMarie Scully, Ana Antun, Spero R Cataland, et al.
Blood|February 17, 2019
Characterization and treatment of congenital thrombotic thrombocytopenic purpuraFerras Alwan, Chiara Vendramin, Ri Liesner, et al.
Blood|June 4, 2017
Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpuraFerras Alwan, Chiara Vendramin, Karen Vanhoorelbeke, et al.
JAMA|July 2, 2021
Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 PandemicMayte Sánchez van Kammen, Mirjam R Heldner, Justine Brodard, et al.
JAMA|May 20, 2019
Effect of a Recombinant Human Soluble Thrombomodulin on Mortality in Patients With Sepsis-Associated Coagulopathy: The SCARLET Randomized Clinical TrialJean-Louis Vincent, Bruno Francois, Igor Zabolotskikh, et al.
Pageof 41